ApoCell
Specializes in molecular biomarker detection and analysis in the areas of oncology, diabetes, molecular diagnostics, and drug development. It has participated in more than 120 phase I, II, and II clinical cancer drug trials, and is currently working on launching a circulating cancer cell detection system that will accelerate the potential for personalized cancer treatment.
2012 STATISTICS
3-year growth:384%
2011 Revenue:$6.8 million
2008 Revenue:$1.4 million
Employees:35
Jobs added, prev. 3 years:19
2012 HONORS
#63
Top 100 Health Companies
#68
Top 100 Texas Companies
#16
Houston Metro Area
PREVIOUS INC. 5000 RANKINGS
2011
753
